Serum zinc levels in patients with multiple warts
Keywords:
Zinc, wart, human papillomavirus, immunity, IranAbstract
Background Although zinc sulphate has been used successfully for the treatment of warts, its mechanism of action is not fully understood. It may work by deficient body stores. The aim of this study was to compare the serum concentration of zinc in patients with multiple warts with normal subjects. Patients and methods In this case-controlled study, 30 patients less than 15 years of age with multiple warts and 30 individuals from the normal population who were matched for age and sex were included. The level of zinc in the serum was measured using flame atomic absorption spectrometry in the two groups. Results The mean serum zinc concentration in the patient and control groups was 55.2±9.6 and 55.8±8.2 µg 100 mL-1, respectively. No significant difference in serum zinc concentration was found between the two groups (p=0.795). However, there was a significant inverse correlation between serum zinc concentrations and the number of warts (β=-1.793, SE=0.646, P=0.002). There was no significant relationship between serum zinc concentration and duration of disease in the patient group (β=-0.129, SE=0.083, p=0.124). Conclusion Serum zinc concentration in patients with multiple warts was not statistically different from control subjects. However, there was an inverse relationship between serum zinc concentration and the number of warts.References
Golden PE, Golden MHN. Plasma zinc, rate of weight gain, and the energy cost of tissue deposition in children recovering from severe malnutrition on a cow’s milk or soya-protein based diet. Am J Clin Nutr 1981; 34: 892-9.
Wellinghausen N, Kirchner H. The immunobiology of zinc. Immunol Today 1997; 18: 519-21.
Ibs KH, Rink L. Zinc altered immune function. J Nutr 2003; 133: 1452-6.
Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol 2008; 43: 370-7.
Rink L, Haase H. Zinc homeostasis and immunity. Trends Immunol 2007; 28: 1-4.
Von Bulow V, Rink L, Hasse H. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-α and IL-1β production in monocytes by elevation of cGMP. J Immunol 2005; 175: 4697-705.
Silverberg NB. Human papillomavirus infections in children. Curr Opin Pediatr 2004; 16: 402-9.
Bender ME. Concepts of wart regression. Arch Dermatol 1986; 122: 644-7.
Kirchner H. Immunobiology of human papillomavirus infection. Prog Med Virol 1986; 33: 1-41.
Tindle RW, Frazer IH. Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunization. Curr Top Microbiol Immunol 1994; 186: 217-53.
Galloway DA, Jenison SA. Characterization of the humoral immune response to genital papillomaviruses. Mol Biol Med 1990; 7: 59-72.
Stanley M, Coleman N, Chambers M. The host response to lesions induced by human papillomavirus. Ciba Found Symp 1994; 187: 21-32.
Sterling JC. Virus infections. In: Burns T, Breathnach S, Cox N, Griffiths CH. Rook's Textbook of Dermatology. London: Blackwell; 2004. p. 25.42.
Sharquie KE, Khorsheed AA, Al-Nuaimy AA. Topical zinc sulphate solution for treatment of viral warts. Saudi Med J 2007; 28: 1418-21.
Sharquie KE, Al-Nuaimy AA. Treatment of viral warts by intralesional injection of zinc sulphate. Ann Saudi Med 2002; 22: 26-8.
Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled trial. Br J Dermatol 2002; 146: 423-31.
Khattar JA, Musharrafieh UM, Tamim H, Hamadeh GN. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts. Int J Dermatol 2007; 46: 427-30.
Kilkenny M, Merlin K, Young R, Marks R. The prevalence of common skin conditions in Australian school students: 1. Common, plane and plantar viral warts. Br J Dermatol 1998; 138: 840-5.
Williams HC, Pottier A, Strachan D. The descriptive epidemiology of warts in British schoolchildren. Br J Dermatol 1993; 128: 504-11.
Gaby AR. Oral zinc for warts. Literature review & commentary - brief article. Townsend Letter for Doctors and Patients august-sep 2003. Available in: [www. findarticles.com].
Pruvost C, Penso-Assathiany D, Bachot N et al. Risk factors for cutaneous wart onset in transplant recipients. Ann Dermatol Venereol 2002; 129: 291-3.
Wilson JD, Brown CB, Walker PP. Factors involved in clearance of genital warts. Int J STD AIDS 2001; 12: 789-92.